Product Description
1. Technical Specifications
|
Manufactured By
|
Zydus
|
|
Dose/Strength
|
4000 IU
|
|
Packaging Type
|
Box
|
|
Usage
|
Hospital,Clinical,Personal
|
|
Form
|
Injection
|
|
Brand
|
Zyrop
|
2. Product Description
Zyrop 4000 IU Injection contains Recombinant Human Erythropoietin Alfa (Epoetin Alfa). It belongs to the class of erythropoiesis-stimulating agents (ESAs) and is used to treat certain types of anemia by stimulating red blood cell production in the bone marrow.
It is indicated for anemia in patients with chronic kidney disease (CKD), anemia induced by chemotherapy, HIV/AIDS therapy (e.g., zidovudine), and to reduce the need for transfusion in surgical procedures.
3. Product Highlights
| Attribute |
Details |
| Generic Name |
Epoetin Alfa |
| Strength |
4000 IU per vial |
| Dosage Form |
Injectable solution (reconstituted) |
| Packaging Type |
Dry vial or liquid injection vial in carton |
| Therapeutic Category |
Hematology / ErythropoiesisStimulating Agent |
| Application Area |
Treat anemia systemically |
| Formulation |
Sterile powder or solution for injection |
| Storage Conditions |
Refrigerate at 28C; do not freeze; protect from light; use at room temperature once ready |
| Shelf Life |
As per batch expirytypically up to 24 months (refer to packaging) |
| Regulatory Compliance |
Manufactured in licensed, GMPcertified facility (Zydus Cadila) |
4. Therapeutic Uses
-
Treatment of anemia due to chronic kidney disease (CKD) in adults and children.
-
Managing anemia associated with chemotherapy in cancer patients.
-
Addressing anemia in HIV patients on zidovudine therapy.
-
Minimizing transfusion needs before major surgery or in
5. Safety Profile & Side Effects
Common side effects:
-
Flu-like symptoms: fever, chills, headache, fatigue, muscle/joint pain, injection site reactions (redness, swelling)
-
Nausea, vomiting, diarrhea, mouth ulcers, weight loss, insomnia, rash, increased blood pressure.
-
Serious risks:
-
Blood clots (thrombosis), stroke, or vascular occlusion.
-
Pure red cell aplasia (rare)
-
Seizures (especially in renal patients)
-
Allergic reactions (angioedema, difficulty breathing)
6. Precautions
-
Prescription-only; administered by healthcare professionals. Self-injection only after proper training.
-
Contraindicated in patients with uncontrolled hypertension, hypersensitivity to erythropoietin, or history of pure red-cell aplasia.
-
Use with caution in conditions such as heart disease, stroke, thrombotic microangiopathy, seizures, or malignancy. Monitor carefully.
-
Pregnancy and breastfeeding: Use only if clearly required and under medical supervision. Avoid multidose vials containing benzyl alcohol.
-
Avoid rapid rises in hemoglobin. Monitor blood pressure, renal and liver function, CBC, iron status regularly.
-
Avoid excessive hemoglobin increase to prevent thrombotic complications
Effective Management of Anemia from Chronic IllnessZyrop 4000IU Injection is specifically recommended for adults managing anemia due to chronic kidney disease or chemotherapy. As a biological medicine, it supports the body in boosting red blood cell count, which can alleviate symptoms like fatigue and breathlessness. Strict administration and monitoring by healthcare professionals ensure optimal benefits and safety for each individual.
Proper Administration by Healthcare ProfessionalsZyrop is delivered via subcutaneous or intravenous injection, and should only be administered by qualified doctors or nursing staff. Each ampoule contains a single prescribed dose4000 IU. To maintain efficacy, store the ampoule in a cool and dry place until use. Adherence to dosing schedules, as suggested by your doctor, is essential for achieving the best results.
Safety and Precautionary MeasuresZyrop 4000IU Injection is a prescription medication that requires cautious use, especially in those with hypertension, a history of thrombosis, pregnancy, or lactation. Doctors will evaluate your medical history carefully before prescribing this medication. Report any side effects promptly and avoid self-administration.
FAQs of Zyrop 4000IU Injection:
Q: How is Zyrop 4000IU Injection administered?
A: Zyrop 4000IU Injection is administered either subcutaneously (under the skin) or intravenously (into a vein) by a healthcare professional. The exact route depends on your doctors determination and the underlying condition being treated.
Q: What conditions is Zyrop 4000IU Injection used to treat?
A: This medication is prescribed to treat anemia caused by chronic kidney disease or chemotherapy. It helps your body produce more red blood cells, reducing symptoms such as fatigue and weakness.
Q: When should Zyrop 4000IU Injection be used with caution?
A: It must be used with caution in individuals who are pregnant, breastfeeding, have high blood pressure, or a history of blood clots. Always inform your doctor about your complete health history before starting treatment.
Q: Where should Zyrop 4000IU Injection be stored?
A: Keep this injection in a cool and dry place according to the packaging instructions to maintain its stability. Do not freeze, and always check the expiration date before use.
Q: What are the benefits of Zyrop 4000IU Injection?
A: The primary benefit is its ability to improve red blood cell production, which combats the fatigue and complications caused by anemia in certain chronic illnesses. Improved hemoglobin levels may enhance your quality of life.
Q: What precautions should I take during Zyrop treatment?
A: Follow your doctors dosage instructions closely and attend all scheduled appointments for monitoring. Promptly report any unusual symptoms, such as increased blood pressure or signs of blood clots.
Q: Is Zyrop 4000IU Injection suitable for self-administration?
A: No. Zyrop Injection must be administered by a doctor or nurse to ensure correct dosage and minimize risks.
Send Email 
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese